Ocular hypertension (OHT)

Ocular hypertension (OHT) is a condition characterized by increased intraocular pressure (IOP), which can lead to damage to the eye structures and, in particular, to the development of glaucoma. This disease does not always manifest itself with obvious clinical symptoms, which makes it especially dangerous, since high pressure may remain unnoticed until irreversible changes occur in the optic nerve. OHT can be primary or secondary, with the secondary form often occurring against the background of other diseases, such as diabetes, various inflammatory eye diseases or injuries. The main criterion for confirming the diagnosis is measuring IOP, which should exceed 21 mm Hg. It is important to note that hypertension does not always lead to glaucoma, but requires careful monitoring and observation.

History of the disease and interesting historical facts

The history of studying ocular hypertension dates back to ancient times. Hippocrates and Galen already described eye diseases in their works, although the mechanism of increased intraocular pressure had no scientific basis at that time. Surrey, in 1738, was the first to describe symptoms that could be associated with increased pressure in the eyes. However, a true cause-and-effect relationship was only established in the 19th century, when the first tonometers were invented. In 1905, the term "glaucoma" was proposed, which became associated with high intraocular pressure. Throughout the 20th century, researchers continued to study the mechanisms of OHT development, and in the 1950s, experiments with drug treatment began, which led to the creation of the first antiglaucoma drugs. It is interesting that disputes between specialists about the meaning of IOP indicators and their role in diagnosing glaucoma continue to this day, but certain criteria remain standard.

Epidemiology

According to various studies, about 3-5% of the population suffers from ocular hypertension. The use of screening methods in recent years has shown that among people over 40 years of age, this figure increases to 10%. At the same time, since many cases remain unrecognized, the actual number of patients may be significantly higher. Depending on the region and ethnicity, the prevalence of OHT may vary, which indicates the need for targeted programs for early detection of this condition. Particularly high incidence is observed in people of African descent, where the risk of developing glaucoma is several times higher. In addition, men and women aged 60 to 80 years are the most vulnerable group.

Genetic predisposition to this disease

Studies show that there is a significant genetic predisposition in patients with ocular hypertension. Genetic markers such as GLC1A and GLC1B have been associated with glaucoma and elevated intraocular pressure. According to the data, about 50% of people with glaucoma have a familial disease, which confirms the potential role of heredity in this process. Moreover, mutations have been identified in genes associated with IOP regulation, including MYOC, CYP1B1, and LTBP2. These data highlight the importance of genetic testing in patients with a family history of ocular hypertension, which may impact risk prediction and the choice of disease prevention methods.

Risk factors for the development of this disease

There are several known risk factors that contribute to the development of ocular hypertension, including:

• Age: Elevated IOP is most often seen in people over 40 years of age.
• Gender: Men have a higher risk than women, especially as they age.
• Family history: Having close relatives with glaucoma significantly increases the likelihood of developing OGT.
• Racial and ethnic factors: People of African and Hispanic descent have a higher risk.
• Obesity: Increased body weight can affect intraocular pressure.
• Diabetes: Underlying metabolic disorders may affect IOP levels.
• Smoking and excessive alcohol consumption: These factors can negatively affect the condition of the blood vessels in the eye.

These risk factors play an important role in the development of strategies for the prevention and early detection of OGTT.

Diagnosis of this disease

Various methods are used to diagnose ocular hypertension, including:

• Main symptoms: Increased intraocular pressure, visual impairment (including blurring, appearance of colored circles), headaches.
• Laboratory tests: Measurement of IOP using tonometry, determination of corneal thickness using anterior segment tomography.
• Radiological examinations: Optical coherence tomography (OCT) is used to evaluate the optic nerve and retina.
• Other types of diagnostics: Visual field testing allows us to identify possible changes at early stages.
• Differential diagnosis: Other conditions such as hypothyroidism or medications that may affect intraocular pressure must be excluded.

Effective diagnosis requires a comprehensive approach and may require regular screening in an ophthalmology practice.

Treatment

Treatment of ocular hypertension can be either medicinal or surgical:

• General treatment: Includes lifestyle changes such as diet and physical activity.
• Pharmacological treatment: The main direction includes the use of eye drops that reduce IOP. These include beta-blockers, prostaglandins and carbonic anhydrase inhibitors.
• Surgical treatment: If conservative therapy is ineffective, surgical intervention such as trabeculectomy or implantation of valves to drain fluid may be recommended.
• Other treatments: Laser therapy (laser trabeculoplasty) may be effective once the diagnosis is made.

The correct choice of treatment method depends on the individual characteristics of the patient and the stage of the disease.

List of medications used to treat this disease

Among the main drugs used to treat ocular hypertension are:

• Timolol (beta blocker)
• Latanoprost (prostaglandin)
• Dorzolamide (carbonic anhydrase inhibitor)
• Brimonidine (alpha agonist)
• Humanoid injectables such as kirtritluk (classification of antiglaucoma drugs).

The choice of a specific drug depends on the patient's condition and the doctor's recommendations.

Disease monitoring

Monitoring of ocular hypertension includes regular checks of IOP and optic nerve function:

• Control stages: It is recommended to conduct examinations at least 1-2 times a year to assess the dynamics of the disease.
• Prognosis: With detection and adequate treatment of ocular hypertension, it is possible to prevent the development of glaucoma and preserve visual function.
• Complications: Without proper monitoring, irreversible changes may develop, including vision loss, which requires constant specialist supervision.

This information highlights the importance of early detection and control of ocular hypertension.

Age-related features of the disease

Ocular hypertension has different manifestations depending on the age group:

• Young people (under 30): Exacerbations and primary forms are usually rare, but can occur in people with a hereditary predisposition.
• Middle age (30-60 years): Highest risk, development of OGT occurs more frequently, requiring regular check-ups.
• Older age (over 60 years): The incidence increases significantly, it is necessary to take into account possible concomitant diseases and complications.

Thus, age-related characteristics require adaptation of diagnostic and treatment methods to each group of patients.

Questions and Answers

• What is ocular hypertension? Ocular hypertension is a condition in which the pressure inside the eye exceeds normal values, which can lead to damage to the optic nerve and vision problems.
• What are the symptoms of ocular hypertension? Symptoms include headaches, blurred vision, and seeing colored rings around lights, although many patients may not experience any sensations.
• How is ocular hypertension treated? Treatment includes medications such as eye drops, pressure reduction, and surgery in more severe cases.
• How often should you get tested for ocular hypertension? It is recommended to undergo examinations at least 1-2 times a year, especially for people aged 40 years and older.
• What risk factors contribute to the development of ocular hypertension? Risk factors include age, gender, obesity, family history, and diabetes, among other associated conditions.

This article aims to provide reliable information about ocular hypertension and its importance in maintaining visual health.